Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common Stock, $.0001 par value
2025-11-18$1.27/sh+5,000$6,350→ 276,421 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.